Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Indomethacin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3715 | ||||
| Docking Score | -7.967 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H16ClNO4 | ||||
| Molecular Weight | 357.8 | ||||
| Canonical SMILES |
CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
|
||||
| InChI |
InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
|
||||
| InChIKey | CGIGDMFJXJATDK-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.3 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | ||
| Xenobiotic Name | Cephradine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 38103 | ||||
| Docking Score | -7.748 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H19N3O4S | ||||
| Molecular Weight | 349.4 | ||||
| Canonical SMILES |
CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
|
||||
| InChIKey | RDLPVSKMFDYCOR-UEKVPHQBSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.4 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Sulfasalazine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5339 | ||||
| Docking Score | -7.743 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H14N4O5S | ||||
| Molecular Weight | 398.4 | ||||
| Canonical SMILES |
C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O
|
||||
| InChI |
InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)
|
||||
| InChIKey | NCEXYHBECQHGNR-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.7 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.